Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1320, pseudogene (RNU6-1320P) is a pseudogene in the human genome derived from the U6 small nuclear RNA gene family[1][5][7][10]. It does not encode a functional product, but instead represents a processed, non-protein-coding fossil remnant of the U6 snRNA gene, most likely generated via retrotransposition[2]. Unlike the canonical U6 snRNA, which is essential in the spliceosomal machinery for pre-mRNA splicing[11], pseudogenes like RNU6-1320P do not have known biological or pathophysiological functions[1][5][10]. There are no known drugs, disease associations, biomarkers, or therapeutic applications attributed to this pseudogene, and it is not considered a therapeutic target. The entry may be flagged as "incorrect" in a therapeutic context because pseudogenes by definition lack the regulatory or coding capacity for typical drug targeting, and searching for this entry as a drug target would be an error[1][5][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1320, pseudogene (RNU6-1320P).